ERK-IN-3 structure
|
Common Name | ERK-IN-3 | ||
---|---|---|---|---|
CAS Number | 2055597-12-9 | Molecular Weight | 473.93 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C22H25ClFN7O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of ERK-IN-3ERK-IN-3 is a potent and oral inhibitor of ERK. ERK-IN-3 inhibits ERK1/2 with low single-digit nM IC50 values. ERK-IN-3 has the potential to be used to study cancers driven by RAS mutations.[1]. |
Name | ERK-IN-3 |
---|
Description | ERK-IN-3 is a potent and oral inhibitor of ERK. ERK-IN-3 inhibits ERK1/2 with low single-digit nM IC50 values. ERK-IN-3 has the potential to be used to study cancers driven by RAS mutations.[1]. |
---|---|
Related Catalog | |
Target |
ERK1 ERK2 |
In Vitro | ERK-IN-3 inhibits the phosphorylation of ERK1/2 substrates such as RSK1, FRA1, and Elk1 in various cell lines[1]. ERK-IN-3 showes single-digit nanomolar antiproliferative activity that is selective for MAPK-pathway dependent cancer cell lines[1]. |
In Vivo | ERK-IN-3 (daily p.o.) inhibits tumor growth in multiple BRAF and KRAS mutant xenograft models in mice and was well tolerated at efficacious doses[1]. |
References |
Molecular Formula | C22H25ClFN7O2 |
---|---|
Molecular Weight | 473.93 |